Analysis of haemophilia B database and strategies for identification of common point mutations in the factor IX gene

Haemophilia

Volumn 9, Issue 2, 2003, Pages 187-192

  Mukherjee, S ^a   Mukhopadhyay, A ^a   Chaudhuri, K ^a   Ray, Kunal ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Bleeding disorder; Cpg; Database; Factor IX; Haemophilia; Mutation

Indexed keywords

BLOOD CLOTTING FACTOR 9; COMPLEMENTARY DNA; METHIONINE; NUCLEOTIDE; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CODON; CPG ISLAND; DATA ANALYSIS; GENE IDENTIFICATION; GENETIC DATABASE; GENETIC VARIABILITY; HAPLOTYPE; HEMOPHILIA B; HUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; RESTRICTION SITE;

EID: 0037366668     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00727.x     Document Type: Article

References (15)

1. Giannelli F, Green PM, High KA et al. Haemophilia B: database of point mutations and short additions and deletions-third edition, 1992. Nucleic Acids Res 1992; 20 Suppl: 2027-63.
2. Koeberl DD, Bottema CD, Ketterling RP, Bridge PJ, Lillicrap DP, Sommer SS. Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene. Am J Hum Genet 1990; 47: 202-17.
3. Gitschier J, Wood WI, Goralka TM et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-30.
4. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
5. Sommer SS, Bowie EJ, Ketterling RP, Bottema CD. Missense mutations and the magnitude of functional deficit: the example of factor IX. Hum Genet 1992; 89: 295-7.
6. Bird AP. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 1980; 8: 1499-504.
7. Ketterling RP, Vielhaber E, Sommer SS. The rates of G:C > T:A and G:C > C:G transversions at CpG dinucleotides in the human factor IX gene. Am J Hum Genet 1994; 54: 831-5.
8. Koeberl DD, Bottema CD, Buerstedde JM, Sommer SS. Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet 1989; 45: 448-57.
9. Green PM, Bentley DR, Mibashan RS, Nilsson IM, Giannelli F. Molecular pathology of haemophilia B. Embo J 1989; 8: 1067-72.
10. Giannelli F, Green PM, Sommer SS et al. Haemophilia B: database of point mutations and short additions and deletions-eighth edition. Nucleic Acids Res 1998; 26: 265-8.
11. Giannelli F, Anagnostopoulos T, Green PM. Mutation rates in humans. Il. Sporadic mutation-specific rates and rate of detrimental human mutations inferred from hemophilia B. Am J Hum Genet 1999; 65: 1580-7.
12. Bottema CD, Ketterling RP, Vielhaber E, Yoon HS, Gostout B, Jacobson DP, et al. The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene. Hum Genet 1993; 91: 496-5O3.
13. Ketterling RP, Bottema CD, Koeberl DD, Ii S, Sommer SS. T296-M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection. Hum Genet 1991; 87: 333-7.
14. Drost JB, Scaringe WA, Jaloma-Cruz AR et al. Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans. Hum Mutat 2000; 16: 203-10.
15. Ketterling RP, Bottema CD, Koeberl DD, Ii S, Sommer SS Evidence that descendants of three founder constitute about 25% of haemophilia B in United States. Genomics 1991; 10: 1093-96.